SMAD4 and infection: Out of all eight targets, only IL1R2, an IL1 decoy receptor, demonstrated enrichment for Smad4 after MP12-infection (average 34.4-fold) as compared to the mock control (5.8-fold; Fig 7A), although these results were not statistically significant.